Lawmakers Press FDA on Getting ALS Therapies to Patients
House lawmakers urged the FDA to be more flexible in reviewing potential therapies for amyotrophic lateral sclerosis (ALS), and other neurodegenerative diseases, during a hearing of the House Energy & Commerce Health Subcommittee on Thursday. Members also stressed the need to increase diversity in and improve access to clinical trials. Each year, 50 million people […]